London, UK — November 17, 2025 — SERB Pharmaceuticals is pleased to announce the appointment of Dr. Vignesh Rajah as its new Chief Medical Officer (CMO).
Dr. Rajah brings over two decades of global experience leading medical and clinical organizations within US and European pharmaceutical and biotech companies. This strategic appointment marks a significant milestone in SERB’s growth journey.
In his role as CMO, Dr. Rajah will play a pivotal role in advancing the company’s scientific and medical capabilities. He will support the launch of new products, deepen engagement with the medical and scientific communities, and identify new opportunities to help patients around the world.
Vanessa Wolfeler, CEO of SERB, remarked, “Vignesh’s unique expertise as both a physician and an experienced CMO reinforces our unwavering commitment to advancing patient care and improving health outcomes. His deep clinical insight and passion for evidence-based innovation will help us realize the full potential of our therapies. Under his leadership, we will sharpen our focus on delivering safe, effective, and compassionate solutions that truly transform patients’ lives. This underscores SERB’s ongoing dedication to medical excellence.”
Dr. Vignesh Rajah expressed his enthusiasm about joining SERB at this pivotal moment: “I’m thrilled to join SERB during such an exciting period of growth. The company’s focus on rare diseases and emergency medicines, along with its commitment to addressing urgent medical needs, aligns strongly with my own values as a physician and medical leader. I look forward to working with our teams and partners in the medical community to bring meaningful innovation to patients worldwide.”
Prior to his appointment, Dr. Rajah was the CMO of US biotech firm Y-mAbs Therapeutics Inc. He has also held senior medical roles at global pharmaceutical companies including Sanofi, Wyeth, and GSK. His experience spans multiple therapy areas, including rare diseases, oncology, immunology, respiratory conditions, and vaccines.
Before transitioning into the industry, Dr. Rajah practiced medicine as a paediatric critical care specialist at major centers of excellence in London.
**About SERB Pharmaceuticals**
SERB is a global specialty pharmaceutical company with a growing portfolio of medicines targeting rare diseases, emergency medicine, and CBRN preparedness. For over 30 years, the company has provided emergency medicines, medical countermeasures, and a leading portfolio of antidotes.
With a strong presence in the US, Europe, and the Middle East, alongside a robust global distribution network, SERB ensures essential medicines are available in over 100 countries. The company’s proven ability to acquire, develop, manufacture, and commercialize specialized medicines enables it to meet critical medical needs with urgency.
By expanding through targeted acquisitions and entering new markets, SERB is committed to not just supplying medicines but also improving the standard of care for patients worldwide.
Learn more at [website link].
https://www.globenewswire.com/news-release/2025/11/17/3188842/0/en/Dr-Vignesh-Rajah-Appointed-as-SERB-Pharmaceuticals-Chief-Medical-Officer.html